Quince adopts 'poison pill' to fend off buyout bid as investor builds stake

Quince Therapeutics is trying to make itself a less appetizing bite for potential buyers to fend off an unsolicited buyout bid from Echo Lake Capital. The “poison pill” is intended to deter investors from accumulating stock on the open market and will kick in once they buy a set percentage of the shares.